Recurrence of the oxazole motif in tubulin colchicine site inhibitors with anti-tumor activity

被引:19
作者
Barreca, Marilia [1 ]
Spano, Virginia [1 ]
Raimondi, Maria Valeria [1 ]
Tarantelli, Chiara [2 ,3 ]
Spriano, Filippo [2 ,3 ]
Bertoni, Francesco [2 ,3 ]
Barraja, Paola [1 ]
Montalbano, Alessandra [1 ]
机构
[1] Univ Palermo, Dept Biol Chem & Pharmaceut Sci & Technol STEBICEF, Via Archirafi 32, I-90123 Palermo, Italy
[2] USI, Fac Biomed Sci, Inst Oncol Res, Via Vincenzo Vela 6, CH-6500 Bellinzona, Switzerland
[3] Oncol Inst Southern Switzerland, Via Osped, CH-6500 Bellinzona, Switzerland
来源
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY REPORTS | 2021年 / 1卷
关键词
Oxazoles; Anti-Tubulin agents; Cancer; Colchicine binding inhibitors; BIOLOGICAL EVALUATION; COMBRETASTATIN A-4; ANTIPROLIFERATIVE ACTIVITY; BRIDGED ANALOGS; TUMOR-GROWTH; DERIVATIVES; ISOXAZOLE; NVP-AUY922; BEARING; DESIGN;
D O I
10.1016/j.ejmcr.2021.100004
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
Because of its wide spectrum of targets and biological activities, the oxazole ring is a valuable heterocyclic scaffold in the design of new therapeutic agents with anticancer, antiviral, antibacterial, anti-inflammatory, neuroprotective, antidiabetic and antidepressant properties. The presence of two heteroatoms, oxygen and nitrogen, offers possible interactions (hydrogen, hydrophobic, van der Waals or dipoles bonds) with a broad range of receptors and enzymes. Furthermore, the oxazole core conjugates low cytotoxicity with improved compound solubility and is well suited to structural modifications such as substitution with different groups and condensation to aromatic, heteroaromatic or non-aromatic rings, offering diversity when introduced into scaffolds. These features make it a very attractive nucleus in medicinal chemistry. Herein we present a diverse array of oxazole derivatives with potential therapeutic use in multiple tumor models. The emphasis has been addressed to compounds with anti-tubulin activity reported in literature in the last decade, describing their structural features, efficiency and future perspectives.
引用
收藏
页数:9
相关论文
共 55 条
[1]   Design, synthesis, and anticancer activity of imidazo[2,1-b]oxazole-based RAF kinase inhibitors [J].
Abdel-Maksoud, Mohammed S. ;
Ammar, Usama M. ;
El-Gamal, Mohammed I. ;
El-Din, Mahmoud M. Gamal ;
Mersal, Karim I. ;
Ali, Eslam M. H. ;
Yoo, Kyung Ho ;
Lee, Kyung-Tae ;
Oh, Chang-Hyun .
BIOORGANIC CHEMISTRY, 2019, 93
[2]   Design, synthesis, and cytotoxic screening of novel azole derivatives on hepatocellular carcinoma (HepG2 Cells) [J].
Abdelhameid, Mohammed K. ;
Zaki, Islam ;
Mohammed, Manal R. ;
Mohamed, Khaled O. .
BIOORGANIC CHEMISTRY, 2020, 101
[3]   Synthesis of [1,2]oxazolo[5,4-e]indazoles as antitumour agents [J].
Barraja, Paola ;
Spano, Virginia ;
Giallombardo, Daniele ;
Diana, Patrizia ;
Montalbano, Alessandra ;
Carbone, Anna ;
Parrino, Barbara ;
Cirrincione, Girolamo .
TETRAHEDRON, 2013, 69 (31) :6474-6477
[4]   Synthesis and Antiproliferative Activity of the Ring System [1,2]Oxazolo[4,5-g]indole [J].
Barraja, Paola ;
Caracausi, Libero ;
Diana, Patrizia ;
Spano, Virginia ;
Montalbano, Alessandra ;
Carbone, Anna ;
Parrino, Barbara ;
Cirrincione, Girolamo .
CHEMMEDCHEM, 2012, 7 (11) :1901-1904
[5]  
Barreca M, 2020, EUR J CANCER, V138, pS35
[6]   An overview on anti-tubulin agents for the treatment of lymphoma patients [J].
Barreca, Marilia ;
Stathis, Anastasios ;
Barraja, Paola ;
Bertoni, Francesco .
PHARMACOLOGY & THERAPEUTICS, 2020, 211
[7]   A Phase I Study of the Hsp90 Inhibitor AUY922 plus Capecitabine for the Treatment of Patients with Advanced Solid Tumors [J].
Bendell, Johanna C. ;
Jones, Suzanne F. ;
Hart, Lowell ;
Pant, Shubham ;
Moyhuddin, Adil ;
Lane, Cassie M. ;
Earwood, Chris ;
Murphy, Patrick ;
Patton, Jeffrey ;
Penley, William C. ;
Thompson, Dana ;
Infante, Jeffrey R. .
CANCER INVESTIGATION, 2015, 33 (10) :477-482
[8]   Novel Combretastatin-2-aminoimidazole Analogues as Potent Tubulin Assembly Inhibitors: Exploration of Unique Pharmacophoric Impact of Bridging Skeleton and Aryl Moiety [J].
Chaudhary, Vikas ;
Venghateri, Jubina B. ;
Dhaked, Hemendra P. S. ;
Bhoyar, Anil S. ;
Guchhait, Sankar K. ;
Panda, Dulal .
JOURNAL OF MEDICINAL CHEMISTRY, 2016, 59 (07) :3439-3451
[9]   Synthesis and Biological Evaluation of Aryloxazole Derivatives as Antimitotic and Vascular-Disrupting Agents for Cancer Therapy [J].
Choi, Min Jeong ;
No, Eun Sun ;
Thorat, Dhanaji Achyutrao ;
Jang, Jae Wan ;
Yang, Hakkyun ;
Lee, Jaeick ;
Choo, Hyunah ;
Kim, Soo Jin ;
Lee, Chang Sik ;
Ko, Soo Young ;
Lee, Jiyoun ;
Nam, GhilSoo ;
Pae, Ae Nim .
JOURNAL OF MEDICINAL CHEMISTRY, 2013, 56 (22) :9008-9018
[10]   Monitoring Combretastatin A4-Induced Tumor Hypoxia and Hemodynamic Changes Using Endogenous MR Contrast and DCE-MRI [J].
Colliez, Florence ;
Fruytier, Anne-Catherine ;
Magat, Julie ;
Neveu, Marie-Aline ;
Cani, Patrice D. ;
Gallez, Bernard ;
Jordan, Benedicte F. .
MAGNETIC RESONANCE IN MEDICINE, 2016, 75 (02) :866-872